glp 1 weight loss study Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment Rx Trends: Real-World Data on
Description
Song, G
"Once-Weekly Semaglutide in Adults with Overweight or Obesity." NEJM
They are also urging patients not to take semaglutide in combination with other diabetes medications unless directed by their doctor
In clinical practice, were seeing more and more patients with Crohns disease who also have overweight or obesity, which adds another layer of complexity to disease management, Ganju said
The Therapeutic Goods Administration (TGA) has confirmed Ozempic's supply shortage in Australia is now resolved, meaning more patients than ever are starting treatment
